North America Facial Aesthetics Market is segmented By Product, By Application, By End-User and – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Market Overview
The North America facial aesthetics market reached US$ 6.93 billion in 2023 and is expected to reach US$ 16 billion by 2031, growing at a CAGR of 11.3% during the forecast period 2024-2031.
Facial aesthetics refers to a type of non-surgical and minimally invasive procedure that can temporarily diminish wrinkles or restore volume. Common treatment areas include the forehead, cheeks, and lips. Facial aesthetic treatments are used to give people a more youthful and radiant appearance. These treatments can soften wrinkles, contour the face, and define certain facial features. Facial aesthetics treatments include Botox, fillers, anti-wrinkle injections, lasers, and deep peels.
Facial aesthetics are also significantly affected by skincare. Maintaining healthy skin through frequent cleansing, moisturizing, and sun protection is essential. Advanced treatments like laser therapy and microneedling can help improve skin quality by treating pigmentation, texture, and elasticity. Overall, facial aesthetics aims to enhance natural beauty while taking into account individual needs and safety, combining art and science to enhance confidence and improve facial appearance.
Market Scope
| Metrics | Details |
| CAGR | 11.3% |
| Market Size | 2022-2031 |
| Market Estimation Forecast Period | 2024-2031 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | Product, Application, and End-User |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter's Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights. |
For more details on this report - Request for Sample
Market Dynamics: Drivers
Increasing adoption of aesthetic procedures among the geriatric population
The rising adoption of aesthetic procedures among the geriatric population propels market growth. For instance, according to the Pew Research Center, the number of Americans ages 100 and older is projected to more than quadruple over the next three decades, from an estimated 101,000 in 2024 to about 422,000 in 2054, according to projections from the U.S. Census Bureau. Centenarians currently make up just 0.03% of the overall U.S. population, and they are expected to reach 0.1% in 2054. The U.S. population overall is expected to trend older in the coming decades as life expectancies increase and the birth rate declines.
There are currently roughly 62 million adults ages 65 and older living in the U.S., accounting for 18% of the population. By 2054, 84 million adults ages 65 and older will make up an estimated 23% of the population. Even as the 65-and-older population continues to grow over the next 30 years, those in their 100s are projected to roughly double as a percentage of that age group, increasing from 0.2% of all older Americans in 2024 to 0.5% in 2054.
Moreover, according to the American Academy of Facial Plastic and Reconstructive Surgery, since 2019, a striking 90 percent or more of AAFPRS surgeons have performed facelifts each year. On average, members performed 48 facelifts or partial facelifts in 2023, demonstrating a 60 percent increase since 2017. Over the past seven years, the number of facelifts performed has steadily increased year over year.
Restraints
Factors such as adverse effects and risks related to facial aesthetic treatments are expected to hamper the market. In some cases side effects such as blepharoptosis, eye sensory disorders, allergic reactions, erythema, oedema, compromised muscle function, blanching, and contour irregularities. Such side effects that are faced as a result of facial aesthetic procedures act as restraints for the facial aesthetics market.
Market Segment Analysis
The North America facial aesthetics market is segmented based on product, application, end-user, and region.
The segment dermal fillers accounted for approximately 34.7% of the North America facial aesthetics market share
The dermal fillers segment is expected to hold the largest market share over the forecast period. In this segment, technological advancements would drive this market.
Dermal fillers are gel-like substances that are injected under the skin to create a smoother or fuller appearance. They are also known as injectable implants, soft tissue fillers, lip and facial fillers, or wrinkle fillers. Dermal fillers are FDA-regulated medical devices. They are typically injected around the eyes, mouth, and nose. Results are usually immediate and can last for months or years. Dermal fillers help to diminish facial lines and restore volume and fullness in the face.
For instance, in June 2024, Evolus Inc., a beauty company with a focus on building an aesthetic portfolio of consumer brands, announced that it had submitted the final module of its premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the Evolysse™ Lift and Evolysse™ Smooth dermal filler products for the nasolabial fold (NLF). Moreover in March 2024, the US Food and Drug Administration (FDA) approved the first and only hyaluronic acid dermal filler for use in the upper face. Allergan Aesthetics' Juvéderm Voluma XC is now approved for the improvement of moderate to severe temple hollows in adult patients aged 21 years and older.
Market Segmentation
By Product
- Dermal Fillers
- Botulinum Toxin
- Chemical Peel
- Microdermabrasion
By Application
- Facial Line Correction Treatment
- Scar Treatment
- Lip Treatments
- Restoration of Volume/ Fullness
- Others
By End-User
- Hospitals
- Specialty Clinics
- Dermatology Clinics
- Others
Competitive Landscape
The major players in the North America facial aesthetics market include Galderma Laboratories L.P, Merz North America Inc., Suneva Medical, Sinclair, AbbVie, Revance Aesthetics, Johnson & Johnson Services Inc., Bausch & Lomb Incorporated, Lutronic Corporation, Candela Corporation among others.
Key Developments
- In November 2023, CollPlant Biotechnologies, a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and organ manufacturing, today announced that the U.S. Patent and Trademark Office has granted a patent that covers CollPlant's photocurable dermal filler product candidate, being developed for the aesthetics market.
- In March 2023, Galderma announced the launch of FACE by Galderma™, an innovative aesthetic visualization tool powered by augmented reality (AR) that allows aesthetic professionals and patients to visualize injectable treatment results* at the planning stage before treatment begins. This innovative solution gives patients a simulated real-time "before and after" visual of what may be possible from an individualized treatment plan and may help alleviate patient concerns about injectable results.
Why Purchase the Report?
- To visualize the North America facial aesthetics market segmentation based on product, application, end-user, and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of North America facial aesthetics market level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping is available in Excel consisting of key products of all the major players.
The North America facial aesthetics market report would provide approximately 51 tables, 54 figures, and 181 Pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
